نتایج جستجو برای: liver fibrosis

تعداد نتایج: 410943  

2015
Zhiming Li Jihong Sun Xiaoming Yang

Liver fibrosis is a life-threatening disease with high morbidity and mortality owing to its diverse causes. Liver biopsy, as the current gold standard for diagnosing and staging liver fibrosis, has a number of limitations, including sample variability, relatively high cost, an invasive nature, and the potential of complications. Most importantly, in clinical practice, patients often reject addi...

Journal: :Annals of hepatology 2013
Abdelfattah M Attallah Sanaa O Abdallah Ahmed A Attallah Mohamed M Omran Khaled Farid Wesam A Nasif Gamal E Shiha Abdel-Aziz F Abdel-Aziz Nancy Rasafy Yehia M Shaker

BACKGROUND Several noninvasive predictive models were developed to substitute liver biopsy for fibrosis assessment. AIM To evaluate the diagnostic value of fibronectin which reflect extracellular matrix metabolism and standard liver functions tests which reflect alterations in hepatic functions. MATERIAL AND METHODS Chronic hepatitis C (CHC) patients (n = 145) were evaluated using ROC curve...

2017
Jie Zeng Ze-Ping Huang Jian Zheng Tao Wu Rong-Qin Zheng

AIM To determine the diagnostic accuracy of two-dimensional shear wave elastography (2D-SWE) for the non-invasive assessment of liver fibrosis in patients with autoimmune liver diseases (AILD) using liver biopsy as the reference standard. METHODS Patients with AILD who underwent liver biopsy and 2D-SWE were consecutively enrolled. Receiver operating characteristic (ROC) curves were constructe...

2010
Han Hyo Lee Yeon Seok Seo Soon Ho Um Nam Hee Won Hanna Yoo Eun Suk Jung Yong Dae Kwon Sanghoon Park Bora Keum Yong Sik Kim Hyung Joon Yim Yoon Tae Jeen Hoon Jai Chun Chang Duck Kim Ho Sang Ryu

The purpose of this prospective study was to verify and compare the strengths of various blood markers and fibrosis models in predicting significant liver fibrosis. One hundred fifty-eight patients with chronic liver disease who underwent liver biopsy were enrolled. The mean age was 41 yr and male patients accounted for 70.2%. The common causes of liver disease were hepatitis B (67.7%) and C (1...

Journal: :Acta biochimica Polonica 2011
Dariusz M Lebensztejn Aldona Wierzbicka Piotr Socha Maciej Pronicki Elżbieta Skiba Irena Werpachowska Maciej Kaczmarski

OBJECTIVES There is a need to replace liver biopsy with non-invasive markers that predict the degree of liver fibrosis in fatty liver disease related to obesity. Therefore, we studied four potential serum markers of liver fibrosis and compared them with histopathological findings in liver biopsy in children with non-alcoholic fatty liver disease (NAFLD). METHODS We determined fasting serum le...

Journal: :American journal of physiology. Gastrointestinal and liver physiology 2007
Penelope C Georges Jia-Ji Hui Zoltan Gombos Margaret E McCormick Andrew Y Wang Masayuki Uemura Rosemarie Mick Paul A Janmey Emma E Furth Rebecca G Wells

Liver fibrosis, the response to chronic liver injury, results from the activation of mesenchymal cells to fibrogenic myofibroblasts. We have recently shown that two key myofibroblast precursor populations, hepatic stellate cells and portal fibroblasts, undergo activation in culture in response to increasing substrate stiffness. We therefore hypothesized that alterations in liver stiffness prece...

2017
Jung Hwan Yu Jung Il Lee

Liver fibrosis is an important prognostic factor for chronic hepatitis B (CHB), and accurate evaluation of the stage of liver fibrosis is crucial in establishing management strategies. While liver biopsy is still considered the gold standard for staging liver fibrosis or cirrhosis, transient elastography (TE), a noninvasive means of assessing liver fibrosis, has come to play an increasing role ...

2018
Krishna Sumanth Nallagangula Shashidhar Kurpad Nagaraj Lakshmaiah Venkataswamy Muninarayana Chandrappa

Liver fibrosis occurs in response to different etiologies of chronic liver injury. Diagnosing degree of liver fibrosis is a crucial step in evaluation of severity of the disease. An invasive liver biopsy is the gold standard method associated with pain and complications. Biomarkers to detect liver fibrosis include direct markers of extracellular matrix turnover and indirect markers as a reflect...

2016
Da-Wu Zeng Jing Dong Jia-Ji Jiang Yue-Yong Zhu Yu-Rui Liu

AIM To develop a non-invasive model to evaluate significant fibrosis and cirrhosis by investigating the association between serum ceruloplasmin (CP) levels and liver fibrosis in chronic hepatitis B (CHB) patients with normal or minimally raised alanine aminotransferase (ALT). METHODS Serum samples and liver biopsy were obtained from 193 CHB patients with minimally raised or normal ALT who wer...

2017
Varinder S Athwal James Pritchett Jessica Llewellyn Katherine Martin Elizabeth Camacho Sayyid Ma Raza Alexander Phythian-Adams Lindsay J Birchall Aoibheann F Mullan Kim Su Laurence Pearmain Grace Dolman Abed M Zaitoun Scott L Friedman Andrew MacDonald William L Irving Indra N Guha Neil A Hanley Karen Piper Hanley

Fibrosis and organ failure is a common endpoint for many chronic liver diseases. Much is known about the upstream inflammatory mechanisms provoking fibrosis and downstream potential for tissue remodeling. However, less is known about the transcriptional regulation in vivo governing fibrotic matrix deposition by liver myofibroblasts. This gap in understanding has hampered molecular predictions o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید